Literature DB >> 31424436

Yeast As a Chassis for Developing Functional Assays to Study Human P53.

Lucilia Saraiva1, Gilberto Fronza2, Alberto Inga3, Paola Monti2, Bartolomeo Bosco4, Sara Gomes1.   

Abstract

The finding that the well-known mammalian P53 protein can act as a transcription factor (TF) in the yeast S. cerevisiae has allowed for the development of different functional assays to study the impacts of 1) binding site [i.e., response element (RE)] sequence variants on P53 transactivation specificity or 2) TP53 mutations, co-expressed cofactors, or small molecules on P53 transactivation activity. Different basic and translational research applications have been developed. Experimentally, these approaches exploit two major advantages of the yeast model. On one hand, the ease of genome editing enables quick construction of qualitative or quantitative reporter systems by exploiting isogenic strains that differ only at the level of a specific P53-RE to investigate sequence-specificity of P53-dependent transactivation. On the other hand, the availability of regulated systems for ectopic P53 expression allows the evaluation of transactivation in a wide range of protein expression. Reviewed in this report are extensively used systems that are based on color reporter genes, luciferase, and the growth of yeast to illustrate their main methodological steps and to critically assess their predictive power. Moreover, the extreme versatility of these approaches can be easily exploited to study different TFs including P63 and P73, which are other members of TP53 gene family.

Entities:  

Mesh:

Year:  2019        PMID: 31424436     DOI: 10.3791/59071

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  6 in total

1.  Tumor suppressor protein p53 expressed in yeast can remain diffuse, form a prion, or form unstable liquid-like droplets.

Authors:  Sei-Kyoung Park; Sangeun Park; Christine Pentek; Susan W Liebman
Journal:  iScience       Date:  2020-12-29

2.  Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay.

Authors:  Paola Monti; Vaclav Brazda; Natália Bohálová; Otília Porubiaková; Paola Menichini; Andrea Speciale; Renata Bocciardi; Alberto Inga; Gilberto Fronza
Journal:  Genes (Basel)       Date:  2021-02-15       Impact factor: 4.096

3.  Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency.

Authors:  Marta Rigoli; Giovanni Spagnolli; Giulia Lorengo; Paola Monti; Raffaello Potestio; Emiliano Biasini; Alberto Inga
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

Review 4.  Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?

Authors:  Paola Monti; Paola Menichini; Andrea Speciale; Giovanna Cutrona; Franco Fais; Elisa Taiana; Antonino Neri; Riccardo Bomben; Massimo Gentile; Valter Gattei; Manlio Ferrarini; Fortunato Morabito; Gilberto Fronza
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

5.  Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.

Authors:  Paola Monti; Marta Lionetti; Giuseppa De Luca; Paola Menichini; Anna Grazia Recchia; Serena Matis; Monica Colombo; Sonia Fabris; Andrea Speciale; Marzia Barbieri; Massimo Gentile; Simonetta Zupo; Mariella Dono; Adalberto Ibatici; Antonino Neri; Manlio Ferrarini; Franco Fais; Gilberto Fronza; Giovanna Cutrona; Fortunato Morabito
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

Review 6.  Yeast as a Tool to Understand the Significance of Human Disease-Associated Gene Variants.

Authors:  Tiziana Cervelli; Alvaro Galli
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.